Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
6.97
-0.13 (-1.83%)
At close: Oct 16, 2026, 4:00 PM EDT
6.87
-0.10 (-1.48%)
After-hours: Oct 16, 2026, 7:30 PM EDT
Immunic Market Cap
Immunic has a market cap or net worth of $95.1 million as of October 16, 2026. It is the 25,623rd most valuable company in the world and the 4,132nd biggest in the United States. Its market cap has increased by 15.14% in one year.
Market Cap
95.10M
Enterprise Value
-59.43M
1-Year Change
15.14%
Global Rank
Country Rank
#4,132 United States
Category
ChartMarket Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $95.10M, a decrease of -60.96%. That is a compound annual growth rate of -11.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 95.10M | 48.14% |
| Dec 31, 2025 | 64.20M | -28.73% |
| Dec 31, 2024 | 90.08M | 33.02% |
| Dec 29, 2023 | 67.72M | 9.04% |
| Dec 30, 2022 | 62.10M | -75.28% |
| Dec 31, 2021 | 251.21M | -20.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cibus | 99.74M |
| PolyPid | 98.51M |
| Kazia Therapeutics | 98.26M |
| PMV Pharmaceuticals | 98.17M |
| Black Diamond Therapeutics | 97.96M |
| Polaryx Therapeutics | 95.70M |
| Rani Therapeutics Holdings | 94.96M |
| PDS Biotechnology | 94.94M |